Publication:
CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial.

dc.contributor.authorCorella, Dolores
dc.contributor.authorAsensio, Eva M
dc.contributor.authorColtell, Oscar
dc.contributor.authorSorlí, José V
dc.contributor.authorEstruch, Ramón
dc.contributor.authorMartínez-González, Miguel Ángel
dc.contributor.authorSalas-Salvadó, Jordi
dc.contributor.authorCastañer, Olga
dc.contributor.authorArós, Fernando
dc.contributor.authorLapetra, José
dc.contributor.authorSerra-Majem, Lluís
dc.contributor.authorGómez-Gracia, Enrique
dc.contributor.authorOrtega-Azorín, Carolina
dc.contributor.authorFiol, Miquel
dc.contributor.authorEspino, Javier Díez
dc.contributor.authorDíaz-López, Andrés
dc.contributor.authorFitó, Montserrat
dc.contributor.authorRos, Emilio
dc.contributor.authorOrdovás, José M
dc.date.accessioned2023-01-25T08:30:33Z
dc.date.available2023-01-25T08:30:33Z
dc.date.issued2016-01-07
dc.description.abstractCircadian rhythms regulate key biological processes influencing metabolic pathways. Disregulation is associated with type 2 diabetes (T2D) and cardiovascular diseases (CVD). Circadian rhythms are generated by a transcriptional autoregulatory feedback loop involving core clock genes. CLOCK (circadian locomotor output cycles protein kaput), one of those core genes, is known to regulate glucose metabolism in rodent models. Cross-sectional studies in humans have reported associations between this locus and obesity, plasma glucose, hypertension and T2D prevalence, supporting its role in cardiovascular risk. However, no longitudinal study has investigated the association between CLOCK gene variation and T2D or CVD incidence. Moreover, although in a previous work we detected a gene-diet interaction between the CLOCK-rs4580704 (C > G) single nucleotide polymorphism (SNP) and monounsaturated (MUFA) intake on insulin resistance, no interventional study has analyzed gene-diet interactions on T2D or CVD outcomes. We analyzed the association between the CLOCK-rs4580704 SNP and incidence of T2D and CVD longitudinally in 7098 PREDIMED trial (ISRCTN35739639) participants after a median 4.8-year follow-up. We also examined modulation by Mediterranean diet (MedDiet) intervention (high in MUFA) on these associations. We observed a significant association between the CLOCK-rs4580704 SNP and T2D incidence in n = 3671 non-T2D PREDIMED participants, with variant allele (G) carriers showing decreased incidence (dominant model) compared with CC homozygotes (HR: 0.69; 95 % CI 0.54-0.87; P = 0.002). This protection was more significant in the MedDiet intervention group (HR: 0.58; 95 % CI 0.43-0.78; P In agreement with our previous results showing a protective effect of the G-allele against hyperglycemia, we extended our findings by reporting a novel association with lower T2D incidence and also suggesting a dietary modulation. Moreover, we report for the first time an association between a CLOCK polymorphism and stroke in T2D subjects, suggesting that core clock genes may significantly contribute to increased CVD risk in T2D.
dc.identifier.doi10.1186/s12933-015-0327-8
dc.identifier.essn1475-2840
dc.identifier.pmcPMC4704407
dc.identifier.pmid26739996
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704407/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1186/s12933-015-0327-8
dc.identifier.urihttp://hdl.handle.net/10668/9710
dc.journal.titleCardiovascular diabetology
dc.journal.titleabbreviationCardiovasc Diabetol
dc.language.isoen
dc.organizationSevilla
dc.page.number4
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.pubmedtypeRandomized Controlled Trial
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.pubmedtypeResearch Support, U.S. Gov't, Non-P.H.S.
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshCLOCK Proteins
dc.subject.meshCardiovascular Diseases
dc.subject.meshChi-Square Distribution
dc.subject.meshCircadian Rhythm
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshDiet, Mediterranean
dc.subject.meshGene Frequency
dc.subject.meshGene-Environment Interaction
dc.subject.meshGenetic Predisposition to Disease
dc.subject.meshHeterozygote
dc.subject.meshHomozygote
dc.subject.meshHumans
dc.subject.meshIncidence
dc.subject.meshKaplan-Meier Estimate
dc.subject.meshLongitudinal Studies
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshMultivariate Analysis
dc.subject.meshPhenotype
dc.subject.meshPolymorphism, Single Nucleotide
dc.subject.meshProportional Hazards Models
dc.subject.meshProtective Factors
dc.subject.meshRisk Assessment
dc.subject.meshRisk Factors
dc.subject.meshSpain
dc.subject.meshTime Factors
dc.subject.meshTreatment Outcome
dc.titleCLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number15
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC4704407.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format